{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:02:30Z","timestamp":1771488150283,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":64,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD074253"],"award-info":[{"award-number":["R01HD074253"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-016-1402-9","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T02:12:26Z","timestamp":1454465546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Viral load monitoring and antiretroviral treatment outcomes in a pediatric HIV cohort in Ghana"],"prefix":"10.1186","volume":"16","author":[{"given":"Omobolawa","family":"Kukoyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Prin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Kusah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elijah","family":"Paintsil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"1402_CR1","unstructured":"UNAIDS. Global Report. UNAIDS report on the global AIDS epidemic 2013 [ http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf ]. Accessed 1 Oct 2015."},{"key":"1402_CR2","unstructured":"Optimizing treatment options and improving access to priority products for children living with HIV Brief [ http:\/\/www.who.int\/hiv\/pub\/toolkits\/paediatric_art_optimisation-brief\/en\/ ]. Accessed 1 Oct 2015."},{"key":"1402_CR3","unstructured":"World Health Organization WH. WHO Early Release Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV September 2015. In. Geneva; 2015. [ http:\/\/www.who.int\/hiv\/pub\/guidelines\/en\/ ]. Accessed 1 Oct 2015."},{"issue":"12","key":"1402_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","volume":"126","author":"JW Mellors","year":"1997","unstructured":"Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946\u201354.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1402_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.296.7.827","volume":"296","author":"SM Hammer","year":"2006","unstructured":"Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, et al. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296(7):827\u201343.","journal-title":"JAMA"},{"key":"1402_CR6","unstructured":"World Health Organization Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for public health approach. [ http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599818_eng.pdf .]. Accessed 20 August 2015."},{"issue":"Suppl 1","key":"1402_CR7","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1002\/cyto.b.20383","volume":"74","author":"BO Taiwo","year":"2008","unstructured":"Taiwo BO, Murphy RL. Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa. Cytometry B Clin Cytom. 2008;74 Suppl 1:S11\u201318.","journal-title":"Cytometry B Clin Cytom"},{"issue":"16","key":"1402_CR8","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.298.16.1888","volume":"298","author":"C Bolton-Moore","year":"2007","unstructured":"Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298(16):1888\u201399.","journal-title":"JAMA"},{"issue":"9","key":"1402_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/QAD.0b013e32832ac34e","volume":"23","author":"MC Hosseinipour","year":"2009","unstructured":"Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS. 2009;23(9):1127\u201334.","journal-title":"AIDS"},{"issue":"4","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/QAI.0b013e3181cf4882","volume":"54","author":"SD Emmett","year":"2010","unstructured":"Emmett SD, Cunningham CK, Mmbaga BT, Kinabo GD, Schimana W, Swai ME, et al. Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study. J Acquir Immune Defic Syndr. 2010;54(4):368\u201375.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1402_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/QAI.0b013e3181fbcbf7","volume":"56","author":"TD Ruel","year":"2011","unstructured":"Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, et al. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2011;56(1):44\u201350.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1402_CR12","doi-asserted-by":"crossref","unstructured":"Davies MA, Ford N, Rabie H, Fatti G, Stinson K, Giddy J, et al. Reducing CD4 Monitoring in Children on Antiretroviral Therapy with Virologic Suppression. Pediatr Infect Dis J. 2015.","DOI":"10.1097\/INF.0000000000000912"},{"key":"1402_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/1471-2334-13-476","volume":"13","author":"O Barry","year":"2013","unstructured":"Barry O, Powell J, Renner L, Bonney EY, Prin M, Ampofo W, et al. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana. BMC Infect Dis. 2013;13:476.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1402_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/jac\/dkp412","volume":"65","author":"D Germanaud","year":"2010","unstructured":"Germanaud D, Derache A, Traore M, Madec Y, Toure S, Dicko F, et al. Level of viral load and antiretroviral resistance after 6\u00a0months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. J Antimicrob Chemother. 2010;65(1):118\u201324.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1402_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/aid.2007.0264","volume":"24","author":"C Adje-Toure","year":"2008","unstructured":"Adje-Toure C, Hanson DL, Talla-Nzussouo N, Borget MY, Kouadio LY, Tossou O, et al. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Cote d'Ivoire. AIDS Res Hum Retrovir. 2008;24(7):911\u20137.","journal-title":"AIDS Res Hum Retrovir"},{"key":"1402_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2431-7-13","volume":"7","author":"A Reddi","year":"2007","unstructured":"Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:13.","journal-title":"BMC Pediatr"},{"issue":"9","key":"1402_CR17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/INF.0b013e3181a458f9","volume":"28","author":"P Jittamala","year":"2009","unstructured":"Jittamala P, Puthanakit T, Chaiinseeard S, Sirisanthana V. Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Pediatr Infect Dis J. 2009;28(9):826\u201330.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1086\/510073","volume":"44","author":"A Calmy","year":"2007","unstructured":"Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, et al. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis. 2007;44(1):128\u201334.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1402_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1086\/600397","volume":"49","author":"FK Sawe","year":"2009","unstructured":"Sawe FK, McIntyre JA. Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes. Clin Infect Dis. 2009;49(3):463\u20135.","journal-title":"Clin Infect Dis"},{"issue":"9709","key":"1402_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","volume":"375","author":"P Mugyenyi","year":"2010","unstructured":"Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, Kityo C, et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010;375(9709):123\u201331.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1402_CR21","first-page":"S34","volume":"10","author":"R Harrigan","year":"1995","unstructured":"Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S34\u201340.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"9622","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0140-6736(08)60624-8","volume":"371","author":"AN Phillips","year":"2008","unstructured":"Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD. Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model. Lancet. 2008;371(9622):1443\u201351.","journal-title":"Lancet"},{"key":"1402_CR23","first-page":"896040","volume":"2011","author":"L Renner","year":"2011","unstructured":"Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and Predictors of CD4+ T-Lymphocytes Recovery in HIV-Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. AIDS Res Treat. 2011;2011:896040.","journal-title":"AIDS Res Treat"},{"issue":"2","key":"1402_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/aje\/kwp347","volume":"171","author":"SR Cole","year":"2010","unstructured":"Cole SR, Napravnik S, Mugavero MJ, Lau B, Eron Jr JJ, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol. 2010;171(2):198\u2013205.","journal-title":"Am J Epidemiol"},{"key":"1402_CR25","unstructured":"Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection [ http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en\/ ]. Accessed 20 Aug 2015."},{"issue":"8","key":"1402_CR26","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/infdis\/jis104","volume":"205","author":"JT Grennan","year":"2012","unstructured":"Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, et al. Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. J Infect Dis. 2012;205(8):1230\u20138.","journal-title":"J Infect Dis"},{"issue":"8","key":"1402_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/hiv.12134","volume":"15","author":"A Zoufaly","year":"2014","unstructured":"Zoufaly A, Kiepe JG, Hertling S, Hufner A, Degen O, Feldt T, et al. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals. HIV Med. 2014;15(8):449\u201357.","journal-title":"HIV Med"},{"issue":"8","key":"1402_CR28","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/infdis\/jir518","volume":"204","author":"S Lambert-Niclot","year":"2011","unstructured":"Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Duvivier C, Haim-Boukobza S, et al. Factors associated with virological failure in HIV-1-infected patients receiving darunavir\/ritonavir monotherapy. J Infect Dis. 2011;204(8):1211\u20136.","journal-title":"J Infect Dis"},{"issue":"4","key":"1402_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018726","volume":"6","author":"F Boufassa","year":"2011","unstructured":"Boufassa F, Saez-Cirion A, Lechenadec J, Zucman D, Avettand-Fenoel V, Venet A, et al. CD4 dynamics over a 15\u00a0year-period among HIV controllers enrolled in the ANRS French observatory. PLoS One. 2011;6(4), e18726.","journal-title":"PLoS One"},{"issue":"2","key":"1402_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00126334-200110010-00001","volume":"28","author":"JW Cohen Stuart","year":"2001","unstructured":"Cohen Stuart JW, Wensing AM, Kovacs C, Righart M, de Jong D, Kaye S, et al. Transient relapses (\"blips\") of plasma HIV RNA levels during HAART are associated with drug resistance. J Acquir Immune Defic Syndr. 2001;28(2):105\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1402_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jinf.2004.11.010","volume":"51","author":"J Macias","year":"2005","unstructured":"Macias J, Palomares JC, Mira JA, Torres MJ, Garcia-Garcia JA, Rodriquez JM, et al. Transient rebounds of HIV plasma viremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy. J Infect. 2005;51(3):195\u2013200.","journal-title":"J Infect"},{"issue":"1","key":"1402_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QAI.0b013e3181b9869f","volume":"53","author":"MT Brady","year":"2010","unstructured":"Brady MT, Oleske JM, Williams PL, Elgie C, Mofenson LM, Dankner WM, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr. 2010;53(1):86\u201394.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"1402_CR33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1056\/NEJM199602153340703","volume":"334","author":"WA O'Brien","year":"1996","unstructured":"O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 1996;334(7):426\u201331.","journal-title":"N Engl J Med"},{"issue":"5265","key":"1402_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","volume":"272","author":"JW Mellors","year":"1996","unstructured":"Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272(5265):1167\u201370.","journal-title":"Science"},{"issue":"6","key":"1402_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nm0696-625","volume":"2","author":"MS Saag","year":"1996","unstructured":"Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, et al. HIV viral load markers in clinical practice. Nat Med. 1996;2(6):625\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"1402_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/COH.0b013e3283333762","volume":"5","author":"L Lynen","year":"2010","unstructured":"Lynen L, Van Griensven J, Elliott J. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings. Curr Opin HIV AIDS. 2010;5(1):1\u20135.","journal-title":"Curr Opin HIV AIDS"},{"issue":"7","key":"1402_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1089\/aid.2013.0025","volume":"29","author":"M Coetzer","year":"2013","unstructured":"Coetzer M, Westley B, Delong A, Tray C, Sophearin D, Nerrienet E, et al. Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines. AIDS Res Hum Retrovir. 2013;29(7):985\u201392.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"12","key":"1402_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/cid\/cir729","volume":"53","author":"HE Rawizza","year":"2011","unstructured":"Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011;53(12):1283\u201390.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1402_CR39","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/135965350701200603","volume":"12","author":"KJ Lee","year":"2007","unstructured":"Lee KJ, Shingadia D, Pillay D, Walker AS, Riordan A, Menson E, et al. Collaborative HIVPSSC: Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean? Antivir Ther. 2007;12(6):949\u201356.","journal-title":"Antivir Ther"},{"issue":"2","key":"1402_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jama.286.2.196","volume":"286","author":"M Hermankova","year":"2001","unstructured":"Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies\/ml receiving combination therapy. JAMA. 2001;286(2):196\u2013207.","journal-title":"JAMA"},{"key":"1402_CR41","volume-title":"IDWeek","author":"OPE Thorvaldsson","year":"2013","unstructured":"Thorvaldsson OPE, Northrup V, Andiman W. Cumulative viremai-copy years predicts morbidity and mortality in perinatally HIV-infected children. In: IDWeek. San Francisco: Infectious Diseases Society of America; 2013."},{"issue":"7","key":"1402_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133452","volume":"10","author":"TM Rossouw","year":"2015","unstructured":"Rossouw TM, Feucht UD, Melikian G, van Dyk G, Thomas W, du Plessis NM, et al. Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa. PLoS One. 2015;10(7), e0133452.","journal-title":"PLoS One"},{"issue":"9","key":"1402_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/cid\/cir526","volume":"53","author":"MJ Mugavero","year":"2011","unstructured":"Mugavero MJ, Napravnik S, Cole SR, Eron JJ, Lau B, Crane HM, et al. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis. 2011;53(9):927\u201335.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1402_CR44","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/QAI.0000000000000289","volume":"67","author":"MA Kowalkowski","year":"2014","unstructured":"Kowalkowski MA, Day RS, Du XL, Chan W, Chiao EY. Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans. J Acquir Immune Defic Syndr. 2014;67(2):204\u201311.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1402_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1086\/599313","volume":"200","author":"A Zoufaly","year":"2009","unstructured":"Zoufaly A, Stellbrink HJ, Heiden MA, Kollan C, Hoffmann C, van Lunzen J, et al. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma. J Infect Dis. 2009;200(1):79\u201387.","journal-title":"J Infect Dis"},{"issue":"1","key":"1402_CR46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/135965350701200106","volume":"12","author":"C Orrell","year":"2007","unstructured":"Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, et al. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther. 2007;12(1):83\u20138.","journal-title":"Antivir Ther"},{"issue":"11","key":"1402_CR47","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2217\/fmb.11.121","volume":"6","author":"L Belec","year":"2011","unstructured":"Belec L, Bonn JP. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less. Futur Microbiol. 2011;6(11):1251\u201360.","journal-title":"Futur Microbiol"},{"issue":"2","key":"1402_CR48","doi-asserted-by":"publisher","first-page":"17324","DOI":"10.7448\/IAS.15.2.17324","volume":"15","author":"T Roberts","year":"2012","unstructured":"Roberts T, Bygrave H, Fajardo E, Ford N. Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc. 2012;15(2):17324.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1402-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1402-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T02:32:53Z","timestamp":1654223573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1402-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1402-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"4 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"58"}}